CLINICAL_TRIALS
trial_result
· 2014-07-01
Clinical Trial Update: Aztreonam Lysine for Pseudomonas Infection Eradication Study [Phase 2]
Summary
Phase 2 trial update for aztreonam lysine aimed at eradicating Pseudomonas infection in cystic fibrosis; the completed study posted results in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2014-07-01